Register entry

Blue Heron Pharmaceuticals, LLC

Data as of · How to read this entry

Registered sites
0
Active NDC listings
11
Labeller names
2
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

11

11 active NDC listings: 8 human otc drug, 3 human prescription drug. By marketing category: UNAPPROVED DRUG OTHER 6, OTC MONOGRAPH DRUG 4, ANDA 1.

Dosage formNDCs
cream4
patch4
liquid2
tablet1
RouteNDCs
topical10
oral1
Labeller name on the listingNDCs
blue heron pharmaceuticals, llc7
blue heron pharmaceuticals llc4
Catalogue

Marketed products

11
BrandGeneric nameForm / routeNDC
Lidocaine 4% PatchLidocaine 4%patch, topical85622-521OTC MONOGRAPH DRUG
Lidocaine 4% PatchLidocaine 4%patch, topical85622-522OTC MONOGRAPH DRUG
MetaxaloneMetaxalonetablet, oral85622-950ANDA
NeuroCool PatchesNeuroCool Patchespatch, topical85622-500OTC MONOGRAPH DRUG
NeuroFreezeMentholliquid, topical85622-511UNAPPROVED DRUG OTHER
NeuroSootheCamphor, Mentholliquid, topical85622-510UNAPPROVED DRUG OTHER
NeurocaineLidocainepatch, topical85622-501OTC MONOGRAPH DRUG
UREDEXUREAcream, topical85622-601UNAPPROVED DRUG OTHER
UREVEXUREAcream, topical85622-605UNAPPROVED DRUG OTHER
UreviaUrea 39cream, topical85622-602UNAPPROVED DRUG OTHER
Urevia PlusUrea 40%cream, topical85622-603UNAPPROVED DRUG OTHER
Compare

Other companies listing lidocaine 4%

Enquiry

Common questions

Is Blue Heron Pharmaceuticals, LLC FDA approved?
Blue Heron Pharmaceuticals, LLC holds no registered establishment of its own; 11 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Blue Heron Pharmaceuticals, LLC make?
11 products are listed under Blue Heron Pharmaceuticals, LLC in the openFDA NDC Directory, most often as cream; patch; liquid. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.